Ostronoff M, Soussain C, Zambon E, Moran A, Droz J P, Bosq J, Bayle C, Cosset J M, Hayat M
Département de Médecine, Institut Gustave Roussy, Villejuif, France.
Nouv Rev Fr Hematol (1978). 1995;37(5):267-72.
The present report concerns a retrospective study of 16 patients with localized intermediate- or high-grade non-Hodgkin's lymphoma of the testis treated in one institution from 1973 to 1990. Ann Arbor stage of disease was IE in 11 and IIE in 5 cases. All except one patient underwent initial inguinal orchidectomy, 11 were disease free after surgery and 12 received inverted Y radiation therapy. All patients achieved a complete remission (CR). Relapse occurred in 8 of 9 patients who did not receive initial chemotherapy, but in only 3 of 7 patients initially treated with chemotherapy including anthracyclins. In 3 cases relapse was confined to the CNS, while diffuse relapse in 8 others included 4 cases of CNS involvement. Eight patients are now alive in CR (5 in first CR, 1 in second CR and 2 in third CR) with a median follow-up of 68.5 months (range 54-101). Chemotherapy thus emerges as the initial treatment of preference for localized testicular lymphoma. Therapy should be preceded by a thorough assessment of the stage of disease and due to the high frequency of CNS relapse, CNS prophylaxis should be considered for all patients.
本报告涉及一项对1973年至1990年在一家机构接受治疗的16例睾丸局限性中或高度非霍奇金淋巴瘤患者的回顾性研究。疾病的Ann Arbor分期为IE期11例,IIE期5例。除1例患者外,所有患者均接受了初始腹股沟睾丸切除术,11例术后无病,12例接受了倒Y形放射治疗。所有患者均实现完全缓解(CR)。未接受初始化疗的9例患者中有8例复发,但在最初接受包括蒽环类药物在内的化疗的7例患者中只有3例复发。3例复发局限于中枢神经系统(CNS),其他8例弥漫性复发包括4例CNS受累。8例患者目前处于CR状态存活(5例处于首次CR,1例处于第二次CR,2例处于第三次CR),中位随访时间为68.5个月(范围54 - 101个月)。因此,化疗成为局限性睾丸淋巴瘤的首选初始治疗方法。治疗前应全面评估疾病分期,由于CNS复发频率高,所有患者均应考虑进行CNS预防。